PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for October 31, 2005 Subscribe to this News Feed    Subscribe to this Podcast Feed
 

Consumers Suffering from Bextra and Vioxx Side Effects Have Hope for Justice as the FDA Puts Pressure on Drug Companies Producing Certain Pain Medications

To support those adversely affected by the pain medication, Bextra, LawyersandSettlements.com promotes free case evaluations by U.S. law firms.

New York City, New York (PRWEB) October 31, 2005 -- Since the recall of Bextra, Pfizer has been the defendant in a number of class action lawsuits in both state and federal courts facing allegations of false advertising, securities fraud, and personal injury related to both Bextra and Celebrex. To seek help, consumers submit their personal grievances with these drugs to LawyersandSettlements.com in hopes of legal representation and compensation.

Since Bextra’s launch in 2001, it has been prescribed to millions of consumers throughout the U.S., Canada, and the European Union as a pain reliever for those suffering from Osteoarthritis, Rheumatoid Arthritis, and severe menstrual cramps (Primary Dysmenorrhea). After an analysis of available information and clinical study results, the FDA concluded that the risks of cardiovascular damage and fatal skin diseases outweighed benefits and asked Pfizer to remove the drug from the U.S. market. Canada and the European Union quickly followed.

After further analysis, the FDA issued a warning label change for all Cox-2 inhibitor drugs and NSAIDS (Bextra, Celebrex, Vioxx, Aspirin, ibuprofen, Aleve, and others) to note an increased risk of cardiovascular (CV) problems and potential life-threatening gastrointestinal (GI) bleeding. To date consumers have linked Bextra with heart attacks/strokes, stomach ulcers, deadly skin diseases Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, anaphylactic shock, and liver damage.

Consumers that have been affected by Bextra and related Cox-2 inhibitor drugs are confident that they will receive justice and compensation as they look to a recent precedent-setting Vioxx lawsuit in which a Texas jury awarded a multi-million dollar settlement to the plaintiff (Case No. 19961- BH02).

LawyersandSettlements.com promotes free case evaluations for those affected by Bextra; to join a Bextra class action lawsuit, submit your case for free legal evaluation by visiting: https://www.lawyersandsettlements.com/case/bextra

About Online Legal Marketing (OLM) and www.lawyersandsettlements.com:
LawyersandSettlements.com offers a comprehensive website with up-to-date legal news, class action lawsuits, personal injury cases, settlement details, product recalls, and more. Consumers can receive free case evaluations. Justice for Everyone.

Visit us at:
http://www.lawyersandsettlements.com/

Contact us at:
604-608-3435

###

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Tracy Laxdal
LAWYERSANDSETTLEMENTS.COM
3603034173
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.